WHO Country Cooperation Strategy Thailand 2017-2021
The Country Cooperation Strategy (CCS) 2017–2021 for Thailand describes WHO’s medium-term strategic vision to guide the Organization’s work in Thailand. Most importantly, it describes five priority programmes on which the Ministry of Public Health in Thailand, its numerous partners, and the World Health Organization will work jointly over the next 5 years. These programmes address some of the critical public health issues facing Thailand in its unique context – an upper-middle-income country that has pioneered universal health coverage and that is committed to improving health through knowledge generation, evidenced-based policy and social/political action. It works to improve systems needed to implement national health policies, strategies and plans, and to achieve national targets under the Sustainable Development Goals.
Joint Mission of the United Nations Interagency Task Force on the Prevention and Control of Noncommunicable Diseases, Thailand 28-30 August 2018
A Joint Programming Mission of the United Nations Interagency Task Force (UNIATF) on the Prevention and Control of Non-Communicable Diseases (NCDs) to Thailand was conducted between 28-30 August 2018 at the invitation of the Government of Thailand. The Joint Mission consisted of representatives from 10 UN agencies and 4 Thai experts. The Mission met with a number of ministries and government agencies as well as civil society organizations, selected private sector entities and academic institutions.
Joint external evaluation of IHR core capacities of the Kingdom of Thailand: mission report: June 26-30, 2017
Thailand has implemented the IHR since they were first introduced in 1969 and has been actively involved in improving the Regulation since the 1980s. Volunteering to host a joint external evaluation (JEE) mission represents a continuation of the country’s engagement in, and leadership of, the IHR and is to be commended. This shows tremendous foresight and demonstrates the Government’s commitment to providing world-class health care to each of its citizens.
Status report on artemisinin and ACT resistance (April 2017)
The WHO Global Malaria Programme issues regular reports about the status of artemisinin resistance in affected countries. The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
